Heiberg, A.; Lampe, C.; Whiteman, D. A. H.
ENZYME REPLACEMENT THERAPY (ERT) IN MPS II PATIENTS AGED 20 YEARS OR OLDER AT TREATMENT INITIATION: DATA FROM THE HUNTER OUTCOME SURVEY (HOS)JOURNAL OF INHERITED METABOLIC DISEASE. Bd. 35. 2012 S. S88-S88
Beetz, R
Evaluation and management of urinary tract infections in the neonateCURRENT OPINION IN PEDIATRICS. Bd. 24. H. 2. 2012 S. 205-211
Langer, D; Bohne, F; Martine, U et al.
Evidence for a functional human network of imprinted genesEUROPEAN JOURNAL OF PEDIATRICS. Bd. 171. H. 9. 2012 S. 1425-1425
Ramaswami, U; Parini, R; Pintos-Morell, G et al.
Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome SurveyCLINICAL GENETICS. Bd. 81. H. 5. 2012 S. 485-490
Burmeister, S; Mildenberger, E; Whybra, C et al.
Falldarstellung: Präpartale Diagnose einer Mucolipidose Typ II mit IUFT in der 30. SSW [Abstract]Z Geburtsh Neonatol. Bd. 216. 2012 S. 83
Berner, R.; Boos, J.; Erdlenbruch, B. et al.
Free first Generation Antihistamine Prescription Position Paper of the Commission for Drug Safety in Children (KASK) of the German Society for Children and Adolescent Medicine (DGKJ)MONATSSCHRIFT KINDERHEILKUNDE. Bd. 160. H. 10. 2012 S. 992-+
Bens, S; Haake, A; Richter, J et al.
Frequency and characterization of DNA methylation defects in children born SGAEur J Hum Genet. 2012 S. Dec12
Zepp, F
Healthcare researchMONATSSCHRIFT KINDERHEILKUNDE. Bd. 160. H. 2. 2012 S. 109-110
Zepp, F; Nowak-Gottl, U
Hemorrhagic skin lesions in children and adolescentsMONATSSCHRIFT KINDERHEILKUNDE. Bd. 160. H. 6. 2012 S. 536-537
Hoffmann, B; Al Sawaf, S; Mayatepek, E et al.
Idursulfatase Therapy in Mucopolysaccharidosis Type II: After 2.5 Years of Treatment-No Benefit for Older Patients With Multisystem Involvement ResponsePEDIATRIC NEUROLOGY. Bd. 46. H. 3. 2012 S. 200-200